Eben Tessari

5 Reasons Pfizer Shouldn't Buy Wyeth

These are all fair points (the MS Office reference was particularly brilliant).

I too, plead ignorance (mostly) as to the details of the merger (I employed by no party in these negotiations), and I'll be the first to admit I'm wrong if this merger is a success, but for the time being I'm going resist the urge to have my de facto position be one of confidence in the Pfizer management team.

I guess we'll find out sooner or later.. and again, phenomenal comment.


On Jan 26 05:51 AM donzelion wrote:

> I'm cautiously optimistic about this merger, but I plead (and vehemently
> affirm) ignorance - because:
>
> (1) Do I know more than Pfizer management about what's in Wyeth's
> pipeline and what the potential value could be? (Anybody who knows
> better than Pfizer management is entitled to an opinion; anyone else
> is an arm-chair quarterback)
>
> (2) Do I know more than Pfizer management about what the potential
> costs and cost savings from the merger? (mergers destroy shareholder
> value - in the sense that one $110 billion company + one $60 billion
> company will not result in one $170 billion company...but that's
> a pretty weak concept of shareholder value...)
>
> (3) Do I know the full scope of the opportunities out there? Pfizer
> could buy 10-50 companies for the money they're looking to spend
> on Wyeth. But that doesn't mean they should...
>
> Two turkeys together may not fly like an eagle - but if you take
> the worst word processor (Microsoft Word version 3.0) and mix it
> with the worst spreadsheet (Excel v. 2.0), use consistent icons and
> keyboard shortcuts - you can take over the world. For a time.